Optimized in vivo multispectral bioluminescent imaging of tumor biology using engineered BRET reporters.

The ability to visualize and track multiple biological processes in vivo in real time is highly desirable. Bioluminescence imaging (BLI) has emerged as an attractive modality for non-invasive cell tracking, with various luciferase reporters enabling parallel monitoring of several processes. However, simultaneous multiplexed imaging in vivo is challenging due to suboptimal reporter intensities and the need to image one luciferase at a time. We report a multiplexed BLI approach using a single substrate that leverages bioluminescence resonance energy transfer (BRET)-based reporters with distinct spectral profiles for triple-color BLI. These luciferase-fluorophore fusion reporters address light transmission challenges and use optimized coelenterazine substrates. Comparing BRET reporters across two substrate analogs identified a green-yellow-orange combination that allows simultaneous imaging of three distinct cell populations in vitro and in vivo . These tools provide a template for imaging other biological processes in vivo during a single BLI session using a single reporter substrate.
Competing Interests: T.A.K. is an employee of Promega Corporation. J.R.W. and T.A.K. are inventors on a patent describing furimazine and furimazine derivatives. A.L.A. is a Global Advisory Board member and paid consultant for LG Chem Life Sciences Innovation Center.
(© 2024 The Author(s).)